Showing results (131-140 of 149) with videos related to
Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2018
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048Ethan Basch, Amylou C Dueck, Lauren J Rogak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2016
Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer ResearchStephanie R Land, Benjamin A Toll, Carol M Moinpour, et al.Archives of Physical Medicine and Rehabilitation|February 1, 2022
Systematic Review of Functional Outcomes in Cancer RehabilitationAlix Sleight, Lynn H Gerber, Timothy F Marshall, et al.International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.Bone Marrow Transplantation|August 10, 2018
Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patientsAna Zelic Kerep, Jacob Broome, Filip Pirsl, et al.Blood|September 25, 2020
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host diseaseLauren M Curtis, Alen Ostojic, David J Venzon, et al.Tumori|June 8, 2022
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)Caterina Caminiti, Jane Bryce, Silvia Riva, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute WorkshopPaul G Kluetz, Bindu Kanapuru, Steven Lemery, et al.Journal of the National Cancer Institute|October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.International Journal of Radiation Oncology, Biology, Physics|May 13, 2024
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp TrialElizabeth A Hahn, Stephanie L Pugh, Hien L Lu, et al.Pageof 15